Four technology appraisals for type 2 diabetes have been updated, and guidance on 4 further medicines is being withdrawn, as part of NICE’s first test of a new way of keeping all its guidance aligned.
NICE recently updated its guideline on type 2 diabetes in adults. Several existing technology appraisals (TAs) for diabetes medicines had fallen out of step with the new recommendations.
New guidance on the management of type 1 diabetes in adults has put greater emphasis on accurate diagnosis amid concerns that the condition is frequently mistaken for type 2 diabetes in people diagnosed later in life.
The updated 2026 consensus report from the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) provides clinicians with clearer recommendations for distinguishing type 1 diabetes from type 2 diabetes and other forms of the condition.
It warns that around 40% of adults diagnosed with type 1 diabetes after the age of 30 are initially misdiagnosed as having type 2 diabetes, with the error more likely to occur among people with overweight or obesity.
A new framework which categorises the outcomes of type 2 diabetes could be instrumental in the drive to alter the progression of the disease and prevent complications.
Researchers from the University of Leicester and the National Institute for Health and Care Research (NIHR) Applied Research Collaboration (ARC) East Midlands are part of a team which has developed the first framework for outcomes relevant to disease modification in type 2 diabetes. Click here.
EASD 2026: Primary care is ‘fundamental’ to tackling global burden of diabetes, researchers stress
Primary care is “uniquely positioned” to drive improvements in diabetes care and tackle this “major global public health crisis”, East Midlands researchers have argued.
Researchers from the University of Leicester and the National Institute for Health and Care Research (NIHR) Applied Research Collaboration (ARC) East Midlands are among the authors of a review which examines the role of primary care on global diabetes management.
Latest figures estimate that 589 million adults aged 20–79 are living with diabetes – around 11.1% of the global population – and cases are increasing at speed, with low- and middle-income countries faring the worst in terms of rising numbers and unmet need.
Debbie Hicks is stepping down as Chair of Trend Diabetes after almost two decades with the organisation, as she prepares to embark on a new chapter travelling the world and ticking off her bucket list.
Debbie has been at the heart of Trend Diabetes since its beginnings in 2009, when she and co-founder June James established the organisation, formerly known as Trend UK.
Since then, she has played a central role in developing Trend Diabetes and building its programme of educational events, conferences and resources for healthcare professionals working in diabetes.
A message from the Insulin Safety Week organisers:
We have received funding by means of sponsorship, including from pharmaceutical and medical technology companies, to support the delivery of our campaign. Insulin Safety Week 2026 has been funded by Roche Diagnostics, MiniMed, Sanofi and Ascensia which have had no input into the campaign's arrangements or content.
University Hospitals Coventry and Warwickshire (UHCW) NHS Trust has been presented with the Insulin Safety Week Excellence Award in recognition of its outstanding contribution to this year’s campaign.
Representatives from Roche Diagnostics, a sponsor of Insulin Safety Week, visited the Trust to present the award to the winning team, celebrating their commitment to improving insulin safety, education and practice across hospital and community services.
Healthcare professionals are being offered new educational support to help recognise chronic kidney disease (CKD) earlier and strengthen its ongoing management as part of a new National Kidney Federation (NKF) campaign.
The charity has launched CKD Connect, an initiative designed to improve knowledge and confidence around CKD among both healthcare professionals and people living with the condition.
Central to the first phase will be a dedicated webinar for healthcare professionals, with a particular focus on supporting primary care teams to recognise CKD earlier and improve its ongoing management.
The initiative has particular relevance for healthcare professionals working in diabetes, where protecting kidney health, identifying CKD and supporting people at risk of disease progression are important aspects of long-term patient care.
Spirit Health and manufacturing partner i-SENS are celebrating CareSens Air achieving the maximum 5/5 study design score in the latest DSN Forum UK CGM Comparison Chart. Click here.
People with type 1 diabetes using multiple daily injections who respond more consistently to smart insulin pen alerts could achieve improved glucose outcomes, according to new six-month randomised trial data. Click here.
The organisers of an inaugural conference which will bring together experts in diabetes, cardiovascular, renal and metabolic care have issued a final call to secure one of the last remaining tickets.
With weeks to go until CVRM Professional Care 2026, healthcare professionals who are keen to attend have been encouraged to book soon to avoid disappointment, as places are limited.
The conference, which is the only event combining cardiovascular, renal and metabolic care under one roof, will be held at Olympia, London on October 20 and 21 and is set to attract 1,500 delegates.
A study by an international group of researchers finds popular diabetes and weight-loss drugs are not linked to pregnancy complications in most women with diabetes.
The results of the study have just been published in The Lancet Obstetrics, Gynaecology & Women’s Health and presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy.
Continuous glucose monitoring could have benefits extending beyond glycaemic management for people with Type 2 diabetes using basal insulin, with CGM use is associated with lower mortality, cardiovascular complications and acute diabetes-related hospitalisations.
Two large studies have provided new evidence on outcomes associated with continuous glucose monitoring (CGM) in people with Type 2 diabetes.
The Cambridge Diabetes Education Programme (CDEP) has launched a new competency-based training topic to give hospital trusts a practical, scalable and auditable way to equip staff with essential diabetes safety knowledge.
For non-specialist staff, recognising and responding appropriately to hypoglycaemia, hyperglycaemic emergencies, insulin-related risks and problems associated with diabetes technology can make a critical difference to patient safety.
In the first of a new opinion series, Dr Partha Kar questions whether NHS diabetes care has reached a tipping point – and whether prioritising just three key areas could be the bold decision needed to reverse declining standards.
Let’s be honest. We are in troubling times. Whether in diabetes care or more broadly, there is no question that there is an underlying anxiety, even among the most optimistic in diabetes care. Things seem to be on a slide compared with where they have been. This may very well be a reflection of the present financial conundrum the NHS finds itself in, and diabetes is no exception to the continued decline the healthcare system faces...read more.
Bringing you the latest jobs from around the country within the field of diabetes.
Consultant in Endocrinology & Diabetes – East Suffolk and North Essex NHS Foundation Trust
Diabetes Specialist Podiatrist – Mid Yorkshire Teaching NHS Trust
Diabetes Nurse – Banbury Cross Health Centre
Diabetic / Diabetes Specialist Nurse – Shefford Health Centre
Join the expanding diabetes community on X and follow us for the latest diabetes news updates at @DiabetesTimes.
We are now on YouTube where you will find interviews with leading figures within the field of diabetes. Click here to visit our page.
